Thymoma Profile at Dr. Moewardi General Hospital: Does Thymoma Size Really Affect Distant Metastasis?
Downloads
Introduction: Size is a predictor factor of a patient's prognosis and metastasis in solid tumors. This study determined the relationship between thymoma size and distant metastasis.
Methods: A cohort retrospective study using medical record data was conducted at Dr. Moewardi General Hospital, Surakarta, from January 2019 to August 2021. Of 1,430 thoracic oncology patients, 150 (10%) had mediastinal mass with thymoma as the majority (48.6%). About 73 thymoma patients were included. The size of the thymoma was the dependent variable, and the metastasis (distant and non-distant) was the independent variable. The cut-off point of thymoma size was determined with receiver operating characteristic (ROC) analysis. The correlation of thymoma size with distant metastasis was analyzed with the Chi-Square test, and p < 0.05 was considered significant.
Results: Thymoma was predominated by males (53.4%), the mean age was 43 ± 16 years old, and dyspnea was the most common symptom. Metastatic lesions were found in 87.7% of the patients, and the most common metastatic sites were intrathoracic (79.5%), followed by axillary lymph nodes (49.3%), bone (21.9%), liver (20.5%), and brain (1.4%). The cut-off value of thymoma size was 8.25 cm, indicating that >8.25 cm was categorized as large thymoma. Distant metastasis was found in 86.0% of large thymoma patients. The large tumors tend to spread into various sites (OR = 5.39; 95% CI 2.8-32.6; p = 0.002).
Conclusion: Thymoma must be taken into account when there are male patients in their forties presented with dyspnea and mediastinal mass. The cut-off point of 8.25 cm for the thymoma size can predict distant metastasis.
Network NCC. Thymomas and Thymic Carcinomas. Philadelphia, https://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf (2023).
Marx A, Chan JKC, Chalabreysse L, et al. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? J Thorac Oncol 2022; 17: 200–213. [PubMed]
Hsu C-H, Chan JK, Yin C-H, et al. Trends in the Incidence of Thymoma, Thymic Carcinoma, and Thymic Neuroendocrine Tumor in the United States. PLoS One 2019; 14: e0227197. [PubMed]
Engels EA. Epidemiology of Thymoma and Associated Malignancies. J Thorac Oncol 2010; 5: S260-5. [PubMed]
Rachmadi MMVL. Aspek Klinik dan Karakteristik Tipe Histopatologik Timoma. Maj Patol Indones 2021; 30: 172–179. [Journal]
Rich AL. Epidemiology of Thymoma. J Thorac Dis 2020; 12: 7531–7535. [PubMed]
Tseng Y-C, Hsu H-S, Lin Y-H, et al. Does Size Affect the Prognosis of Resectable Thymoma beyond the Eighth Edition TNM? Thorac Cancer 2022; 13: 346–352. [PubMed]
Han X, Gao W, Chen Y, et al. Relationship between Computed Tomography Imaging Features and Clinical Characteristics, Masaoka-Koga Stages, and World Health Organization Histological Classifications of Thymoma. Front Oncol 2019; 9: 1041. [PubMed]
Minervini F, Kocher GJ. When to Suspect a Thymoma: Clinical Point of View. J Thorac Dis 2020; 12: 7613–7618. [PubMed]
Khandelwal A, Sholl LM, Araki T, et al. Patterns of Metastasis and Recurrence in Thymic Epithelial Tumours: Longitudinal Imaging Review in Correlation with Histological Subtypes. Clin Radiol 2016; 71: 1010–1017. [PubMed]
Okumura M, Yoshino I, Yano M, et al. Tumour Size Determines both Recurrence-Free Survival and Disease-Specific Survival after Surgical Treatment for Thymoma. Eur J Cardiothorac Surg 2019; 56: 174–181. [PubMed]
Abdel Jalil R, Abdallah FA, Obeid Z, et al. Locally Advanced Thymoma; Does Neoadjuvant Chemotherapy Make a Difference? J Cardiothorac Surg 2023; 18: 245. [PubMed]
Xu J, Ding X, Wang L, et al. The Clinicopathologic Features and Management of Recurrent Thymoma. Clin Surg 2022; 7: 1–4. [Journal]
Otsuka S, Hiraoka K, Kimura N, et al. Invasive Thymoma Metastases to the Pancreas: A Case Report. International Journal of Surgery Case Reports 2023; 105: 108004. [PubMed]
Wu C-W, Yang T-L. Spleen Metastasis of Recurrent Malignant Thymoma. Journal of Surgical Case Reports 2022; 2022: rjac375. [PubMed]
Bian D, Zhou F, Yang W, et al. Thymoma Size Significantly Affects the Survival, Metastasis and Effectiveness of Adjuvant Therapies: A Population Based Study. Oncotarget 2018; 9: 12273–12283. [PubMed]
Yun JK, Kim HR, Kim DK, et al. Tumor Size as a Prognostic Factor in Limited-Stage Thymic Epithelial Tumors: A Multicenter Analysis. J Thorac Cardiovasc Surg 2021; 162: 309-317.e9. [PubMed]
Fukui T, Fukumoto K, Okasaka T, et al. Prognostic Impact of Tumour Size in Completely Resected Thymic Epithelial Tumours. Eur J Cardiothorac Surg 2016; 50: 1068–1074. [PubMed]
Hwang Y, Park IK, Park S, et al. Lymph Node Dissection in Thymic Malignancies: Implication of the ITMIG Lymph Node Map, TNM Stage Classification, and Recommendations. J Thorac Oncol 2016; 11: 108–114. [PubMed]
Amini A, Rusthoven CG. Thymoma: Does Tumor Size Matter? Journal of Thoracic Disease 2019; 11: S2005–S2007. [PubMed]
Singh G, Amin Z, Wuryantoro, et al. Profile and Factors Associated with Mortality in Mediastinal Mass during Hospitalization at Cipto Mangunkusumo Hospital, Jakarta. Acta Med Indones 2013; 45: 3–10. [PubMed]
Nikita SMO, Widiastuti W, Rima A, et al. The Relationship between CT Scan and Incidence of Intrathoracic Thymoma Metastases in Dr. Moewardi General Hospital, Surakarta. Bali Med J 2021; 10: 741–745. [Journal]
Suryaman R, Djajalaksana S, Setyawan U, et al. Thymoma (Case Report): Importance of Comorbidity, Lifestyle, and Thymoma Size in Treatment Success. Malang Respir J 2022; 4: 251–264. [Journal]
Burt BM, Shrager JB. Benign and Malignant Neoplasms of the Mediastinum. In: Grippi MA, Elias JA, Fishman JA, et al. (eds) Fishman's Pulmonary Diseases and Disorders. New York, NY: McGraw-Hill Education, http://accessmedicine.mhmedical.com/content.aspx?aid=1122363861 (2015).
Hussein SA, Sabri YY, Fouad MA, et al. Role of Different Imaging Modalities in the Evaluation of Normal and Diseased Thymus. Egypt J Bronchol 2020; 14: 5. [Journal]
Liou DZ, Ramakrishnan D, Lui NS, et al. Does Size Matter? A National Analysis of the Utility of Induction Therapy for Large Thymomas. J Thorac Dis 2020; 12: 1329–1341. [PubMed]
Zhang Y, Lin D, Aramini B, et al. Thymoma and Thymic Carcinoma: Surgical Resection and Multidisciplinary Treatment. Cancers (Basel); 15. Epub ahead of print March 2023. [PubMed]
Khorfan R, Bharat A, Odell DD. Management and Long-Term Outcomes of Advanced Stage Thymoma in the United States. Ann Thorac Surg 2021; 111: 223–230. [PubMed]
Copyright (c) 2024 Novita Silvana Thomas, Fahlevie Fahlevie, Ana Rima Setijadi, Widiastuti Widiastuti, Sastia Rakhma
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (